PhiKan 083 hydrochloride is primarily utilized in the field of medicinal chemistry and drug development. It is specifically known for its role in targeting and stabilizing mutant p53 proteins, which are often implicated in various cancers. By binding to and stabilizing these mutant proteins, it helps restore their tumor-suppressing functions, making it a potential therapeutic agent in cancer treatment. Researchers are actively exploring its application in preclinical studies to evaluate its efficacy in inhibiting tumor growth and improving patient outcomes. Additionally, it serves as a valuable tool in biochemical research for understanding the mechanisms of p53-related pathways and developing novel anticancer therapies.